Evidence map›Paper›PMID 37558659›Full record

ArticleBlood cancer journal2023

Coincidence of cutaneous blastic plasmacytoid dendritic cell neoplasm and myelodysplastic syndrome derived from clonal hematopoiesis.

Tomohiko Yamada, Nobuhiro Hiramoto, Takuto Mori, Daisuke Yamashita, Yukimasa Tai, Ryusuke Yamamoto, Masashi Nishikubo, Hayato Maruoka, Kana Sakamoto, Kengo Takeuchi and 3 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Tomohiko YamadaDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
Nobuhiro HiramotoDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan. kvlqt1789@gmail.com.ORCID http://orcid.org/0000-0002-0472-6680
Takuto MoriDepartment of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
Daisuke YamashitaDepartment of Pathology, Kobe City Medical Center General Hospital, Kobe, Japan.
Yukimasa TaiDepartment of Dermatology, Kobe City Medical Center General Hospital, Kobe, Japan.
Ryusuke YamamotoDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
Masashi NishikuboDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
Hayato MaruokaDepartment of Clinical Laboratory, Kobe City Medical Center General Hospital, Kobe, Japan.
Kana SakamotoDivision of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
Kengo TakeuchiDivision of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
Yasuhito NannyaDepartment of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
Seishi OgawaDepartment of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0002-7778-5374
Takayuki IshikawaDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematologic NeoplasmsMyelodysplastic SyndromesMyeloproliferative DisordersNeoplasmsSkin NeoplasmsAcute DiseaseClonal HematopoiesisDendritic CellsHumans

Identifiers

PMID37558659
PMCPMC10412548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.